These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38043734)

  • 21. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation.
    Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M
    J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute cardiac failure secondary to senile systemic amyloidosis.
    Bodard Q; Roca F; Dilly B; Laurent D; Chassagne P
    Age Ageing; 2016 Nov; 45(6):908-909. PubMed ID: 27103598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions.
    Khedraki R
    Curr Opin Cardiol; 2022 May; 37(3):272-284. PubMed ID: 35612939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Reliable Baton Passing From Orthopedic Surgeon to Cardiologist　- Cardiac Screening in Patients With Carpal Tunnel Syndrome for Early Diagnosis of Transthyretin Amyloid Cardiomyopathy.
    Ikura H; Kitakata H; Endo J
    Circ J; 2023 Jul; 87(8):1056-1057. PubMed ID: 37438146
    [No Abstract]   [Full Text] [Related]  

  • 25. Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review.
    Papathanasiou M; Carpinteiro A; Kersting D; Jakstaite AM; Hagenacker T; Schlosser TW; Rischpler C; Rassaf T; Luedike P
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1581. PubMed ID: 33345470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tafamidis in patients with severe heart failure due to transthyretin amyloidosis cardiomyopathy: Improved long-term survival.
    Tubben A; Nienhuis HLA; van der Meer P
    Eur J Heart Fail; 2023 Nov; 25(11):2065-2066. PubMed ID: 37792736
    [No Abstract]   [Full Text] [Related]  

  • 27. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.
    Maurer MS; Bokhari S; Damy T; Dorbala S; Drachman BM; Fontana M; Grogan M; Kristen AV; Lousada I; Nativi-Nicolau J; Cristina Quarta C; Rapezzi C; Ruberg FL; Witteles R; Merlini G
    Circ Heart Fail; 2019 Sep; 12(9):e006075. PubMed ID: 31480867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and treatment of cardiac transthyretin amyloidosis. Innovative therapy with tafamidis.].
    Legrand D; Nyssen A; Jackers L; Brogneaux C; Pirotte I; Grayet D; Lacremans D; Magnée M
    Rev Med Liege; 2022 Jan; 77(1):63-68. PubMed ID: 35029343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of transthyretin-related amyloidosis cardiomyopathy.
    Teng C; Li P; Bae JY; Pan S; Dixon RAF; Liu Q
    Clin Cardiol; 2020 Nov; 43(11):1223-1231. PubMed ID: 32725834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When to Suspect and How to Approach a Diagnosis of Amyloidosis.
    Law S; Gillmore JD
    Am J Med; 2022 Apr; 135 Suppl 1():S2-S8. PubMed ID: 35081377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time Course of Common Clinical Manifestations in Patients with Transthyretin Cardiac Amyloidosis: Delay From Symptom Onset to Diagnosis.
    Papoutsidakis N; Miller EJ; Rodonski A; Jacoby D
    J Card Fail; 2018 Feb; 24(2):131-133. PubMed ID: 29305186
    [No Abstract]   [Full Text] [Related]  

  • 33. Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
    Siontis GC; Windecker S
    J Am Coll Cardiol; 2015 Jan; 65(3):313. PubMed ID: 25614435
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
    Kim WK; Rolf A; Möllmann H
    J Am Coll Cardiol; 2015 Jan; 65(3):312-3. PubMed ID: 25614434
    [No Abstract]   [Full Text] [Related]  

  • 35. A representative case of hereditary transthyretin amyloidosis complicated by intramyocardial hemorrhage.
    Yagi H; Amiya E; Shintani Y; Nitta D; Numakura S; Hosoya Y; Watanabe M; Fukayama M; Komuro I
    Amyloid; 2015 Mar; 22(1):70-2. PubMed ID: 25427692
    [No Abstract]   [Full Text] [Related]  

  • 36. Days alive and outside of hospital from diagnosis of transthyretin vs. light chain cardiac amyloidosis.
    Rubin J; Teruya S; Helmke S; De Los Santos J; Alvarez J; Maurer MS
    Amyloid; 2019; 26(sup1):4-5. PubMed ID: 31343342
    [No Abstract]   [Full Text] [Related]  

  • 37. From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis.
    Petkow-Dimitrow P; Rajtar-Salwa R; Holcman K; Kostkiewicz M; Rubiś P
    Pol Arch Intern Med; 2020 Feb; 130(2):153-154. PubMed ID: 31933485
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of Transthyretin Cardiac Amyloidosis Among Patients Previously Diagnosed With Hypertrophic Cardiomyopathy.
    Rowin EJ; Ruberg FL; Das G; Higgins D; Lipe WC; Bokhari N; Dehn M; Maron BJ; Maron MS
    Circ Cardiovasc Imaging; 2022 Dec; 15(12):e014938. PubMed ID: 36448453
    [No Abstract]   [Full Text] [Related]  

  • 39. Transthyretin Variant Amyloidosis with a TTR A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy.
    Ikeda K; Yamamoto D; Usui K; Takeuchi H; Oka N; Katoh N; Yazaki M; Kametani F; Nishino I; Hisahara S
    Intern Med; 2023 Aug; 62(15):2261-2266. PubMed ID: 36543209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.
    Galant NJ; Westermark P; Higaki JN; Chakrabartty A
    Clin Sci (Lond); 2017 Mar; 131(5):395-409. PubMed ID: 28213611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.